Skip to content

Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis

Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04627857
Acronym
ScleroBross
Enrollment
20
Registered
2020-11-13
Start date
2021-07-01
Completion date
2026-06-01
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma Systemic

Brief summary

Systemic sclerosis is a rare multisystem connective-tissue disorder characterized by three major pathological hallmarks: widespread fibrosis, vasculopathy and immunological abnormalities. This condition has multiple effects on the orofacial region that is involved in approximately 80% of the patients with a significant impact on the quality of life. The aim of this randomized single-blind study is to evaluate the impact of the use of a specific oral hygiene instrumentation (sonic toothbrush and water flosser with a large handle) compared to "standard" toothbrushing with a manual toothbrush on the gingival health among patients with systemic sclerosis.

Interventions

DEVICEManual toothbrush

Patients in group 1 (''reference procedure'') receive a manual toothbrush with a small compact head to facilitate access to the posterior teeth and soft bristles.

DEVICEManual toothbrush and water flosser (Philips Sonicare AirFloss)

\- Group 2 patients receive a manual toothbrush with a small, compact head for easy access to the posterior teeth and soft bristles. They also receive a Philips brand interdental microjet (Philips Sonicare AirFloss Ultra) which must be filled with water.

\- Group 3 patients receive a rechargeable sonic electric toothbrush from Philipps with an integrated excess pressure sensor and a compact toothbrush head for easy access to the posterior teeth.

DEVICESonic toothbrush (Philips Sonicare) and water flosser (Philips Sonicare AirFloss)

\- Group 4 patients receive a Philips Sonicare ProtectiveClean rechargeable sonic electric toothbrush with an integrated excess pressure sensor and 2 compact toothbrush heads for easy access to the posterior teeth. They also receive an interdental microjet from Philips (Philips Sonicare AirFloss Ultra) which must be filled with water.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult male or female ≥ 18 years (18th birthday completed) * Affiliation to a social welfare system * Signed informed consent form * More than 12 natural teeth suitable for evaluation * Systemic sclerosis with cutaneous involvement with a diagnosis based on American College of Rheumatology (ACR) and LeRoy and Metzger criteria

Exclusion criteria

* Localized scleroderma or systemic sclerosis without cutaneous involvement ("sine scleroderma" limited form) * Less than 12 natural teeth suitable for evaluation and/or mandibular/maxillary complete denture(s) * Other progressive chronic illness /autoimmune disease other than systemic sclerosis (e.g. diabetes) * Another cause of mucocutaneous sclerosis (e.g. radiotherapy involving the oro-facial region) * Current use of sonic toothbrush and/or dental water flosser * Severe manual handicap preventing the patient from holding a toothbrush with a large handle * Oral antiseptics (e.g. chlorhexidin mouthwashes) * Ongoing medical treatment inducing a significant modification of the gingival state (e.g. anti-epileptic drugs) * Smoking (≥ 10 cigarettes per day) * Impossibility to provide accurate information (e.g. emergency situation, comprehension difficulties) * Individual under guardianship, curatorship or judicial protection

Design outcomes

Primary

MeasureTime frame
Changing of plaque index between baseline, week 2 and week 4day 0, week 2 and week 4

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026